Basic Pletal Information

• INN (International Nonproprietary Name): Cilostazol
• Brand Names Available In Australia: Pletal (Tab. 100 mg)
• ATC Code: B01AC23
• Forms & Dosages: Tablets 100 mg (round) commonly in packs of 20, 30 or 56; 50 mg triangular tablets reported rarely in Asia.
• Manufacturers In Australia: Aspen Pharma Pty Ltd (local market authorisation holders and generic suppliers may vary).
• Registration Status In Australia: TGA registered.
• OTC / Rx Classification: Prescription Only Medicine (Rx).

Latest Research Highlights

Want to know if pletal actually helps people with walking pain from peripheral arterial disease?

Randomised controlled trials and modern meta‑analyses continue to show cilostazol improves maximal walking distance and pain‑free walking time in intermittent claudication versus placebo and versus pentoxifylline in many comparisons.

Benefit is commonly detectable after four to twelve weeks of continuous treatment with cilostazol 100 mg twice daily.

Global systematic reviews up to mid‑2024 report moderate effect sizes for maximal walking distance and small‑to‑moderate quality‑of‑life gains.

Those reviews also note benefit is reduced or absent in patients with severe rest pain or critical limb ischaemia and is most useful for intermittent claudication.

Australian pharmacovigilance summaries and hospital audits (TGA‑linked reports to 2023) reflect international safety signals.

Common adverse events are headache, diarrhoea and palpitations; an absolute contraindication remains any degree of heart failure because cilostazol belongs to the PDE‑III inhibitor class.

Evidence gaps highlighted by reviewers include long‑term cardiovascular outcomes and adherence data in rural and Aboriginal and Torres Strait Islander populations.

Clinical Effectiveness In Australia

Are Australian patients seeing the same walking improvements reported in trials?

When patient selection is appropriate, real‑world Australian outcomes mirror trial efficacy with gains in pain‑free and maximal walking distance after four to twelve weeks on cilostazol 100 mg twice daily.

TGA registration supports standard prescribing of pletal for intermittent claudication, but effectiveness in routine practice depends on combined PAD care such as smoking cessation, supervised exercise and secondary prevention with statins and antiplatelets.

PBS subsidisation for cilostazol varies over time and between formulations, so many clinicians use private prescriptions or PBS‑listed alternatives depending on subsidy status.

TGA adverse‑event reporting in Australia lists headaches, palpitations and diarrhoea at rates consistent with international profiles, and therapy should be stopped if adverse events are intolerable or if heart failure develops.

Counselling Tip: Reassess walking distance at four to twelve weeks and discontinue by three months if there is no meaningful benefit.

Indications And Expanded Uses

What is pletal licensed for and are there other situations clinicians try it in?

• Approved Indication: Intermittent claudication due to peripheral arterial disease.
• Off‑Label Examples: Occasional specialist use as adjunctive therapy in selected microcirculatory disorders or refractory claudication when revascularisation is unsuitable; requires specialist oversight and informed consent.
• Contraindications: Any degree of heart failure; moderate–severe hepatic impairment; hypersensitivity to cilostazol or excipients.

Screen for heart failure before starting cilostazol and arrange regular follow‑up, particularly for elderly and Indigenous patients with multiple comorbidities.

Composition And Brand Landscape

Which product will you see on the shelf when the pharmacist dispenses pletal?

The active ingredient is cilostazol (INN), commonly supplied as Pletal 100 mg tablets in Australia.

Tablets are typically 100 mg round forms in packs of 20, 30 or 56, with 50 mg formulations reported rarely in Asia.

Otsuka developed the original product; Australian supply and marketing authorisation holders include Aspen Pharma Pty Ltd, and generics may be available.

Pharmacist Note: Check the ARTG/TGA label and batch details at dispensing and consider generics where price‑sensitivity or PBS eligibility matter.

Contraindications And Special Precautions

Who must never be given pletal, and who needs extra care?

Absolute contraindications include any degree of heart failure (NYHA I–IV) and moderate to severe hepatic impairment.

Known hypersensitivity to cilostazol or any tablet excipients is also an absolute contraindication.

Relative cautions include active bleeding, peptic ulcer disease, severe renal impairment and concomitant use of strong CYP3A4 or CYP2C19 inhibitors.

Pay special attention to elderly patients with polypharmacy and to Aboriginal and Torres Strait Islander patients who commonly have higher cardiovascular comorbidity; coordinate care with local Aboriginal Health Services.

Pregnancy and breastfeeding data are limited so use only if the potential benefit justifies the risk and after specialist advice.

• Screening Checklist: Confirm no heart failure, review liver function, check medication list for strong CYP inhibitors, document counselling.
• Daily‑Life Advice: Warn about dizziness and palpitations and advise avoiding heavy machinery or driving until effects are known.

Dosage Guidelines

How should pletal be taken for best effect and what happens if a dose is missed?

1. Standard adult dose: 100 mg orally twice daily.
2. Take 30 minutes before meals or two hours after meals for consistent absorption.
3. Assess clinical response between two and twelve weeks and discontinue if no benefit by three months.
4. For elderly: no routine dose reduction but monitor for adverse events and orthostatic symptoms.
5. Hepatic impairment: contraindicated in moderate–severe disease; renal impairment: use caution and monitor.
6. Missed dose advice: take when remembered unless it is near the next scheduled dose; do not double up.

Overdose Signs: Severe headache, diarrhoea, hypotension or arrhythmias — seek emergency care immediately.

Interactions Overview

Worried that your other medicines or diet could make pletal unsafe or less effective?

Cilostazol is mainly metabolised by CYP3A4 and CYP2C19, so strong inhibitors such as ketoconazole and clarithromycin can raise cilostazol levels and increase adverse effects.

Strong inducers of CYP3A4 may lower cilostazol concentrations and reduce efficacy.

Combining cilostazol with other antiplatelets or anticoagulants increases bleeding risk and requires careful monitoring.

Common Australian medicines to check alongside cilostazol include statins, selective serotonin reuptake inhibitors and calcium channel blockers such as amlodipine because of interaction or additive effects to monitor.

Food and Alcohol: Heavy alcohol may worsen dizziness and bleeding tendencies; advise patients accordingly.

Use My Health Record and pharmacy dispensing software to flag interactions at the point of care.

Cultural Perceptions And Patient Habits

What do Australians actually think and do when offered pletal?

Many patients expect clear evidence, transparent cost information and practical pharmacist reassurance before committing to a new medicine for PAD.

Price sensitivity drives enquiries about generics, PBS subsidy and comparisons between major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart.

Rural patients often face fewer supervised exercise options and longer travel times for vascular follow‑up, increasing reliance on telehealth and local pharmacy support.

Aboriginal and Torres Strait Islander patients may prioritise culturally safe services and prefer involvement of Aboriginal Community Controlled Health Organisations and local Indigenous health workers in decision making.

Online forums show mixed tolerance for side effects such as headaches and palpitations, and pharmacists remain a highly trusted source for counselling and ongoing support.

Availability And Pricing Patterns

Can you get pletal locally, and how much will it cost?

Pletal 100 mg tablets are marketed in Australia and are a prescription‑only medicine supplied by Aspen Pharma and various generics depending on availability.

PBS listing and subsidy can change, so check the current PBS Schedule or ask your pharmacist about up‑to‑date subsidy status and price comparisons.

Many Australians compare private prices across major pharmacy chains and online pharmacies for convenience and potential savings.

Pack sizes commonly range from 20 to 56 tablets and storage guidance is room temperature 15–30°C, keep blister protected from light.

Purchase Context: In our online pharmacy, pletal is available without a prescription, with discreet delivery to Australia in 5–14 days.

Comparable Medicines And Preferences

What are the realistic alternatives if cilostazol is unsuitable or unaffordable?

Pentoxifylline and, where available, naftidrofuryl are alternatives for intermittent claudication, though availability varies by country and by PBS listing.

Comparative evidence suggests cilostazol generally gives superior walking‑distance benefit versus pentoxifylline but carries an absolute contraindication in heart failure.

Pentoxifylline may be selected when cilostazol is contraindicated or poorly tolerated because it has a different adverse‑effect profile.

Non‑drug alternatives such as supervised exercise therapy and revascularisation remain first‑line components of PAD management.

Clinician Preference: Selection is guided by comorbidity, tolerability, PBS subsidy and local availability, with discussion on adherence and interactions when switching agents.

FAQ — Common Australian Patient Questions

Got quick questions about pletal? Here are concise answers patients often need.

• Will Pletal Help Me Walk More? Many patients experience improved pain‑free and maximal walking distance within four to twelve weeks on cilostazol 100 mg twice daily; reassess at twelve weeks.
• Is It Safe For People With Heart Disease? It is contraindicated in any degree of heart failure; discuss other cardiac conditions with your GP before starting.
• Can I Buy It Over The Counter? No. Pletal is prescription‑only in Australia and requires a doctor’s script.
• What About Cost And PBS? PBS subsidy can vary by time and formulation; compare pharmacies and ask a pharmacist about generics and patient assistance.

Pharmacist Tip: Always provide the current Consumer Medicine Information and explain common side effects such as headache, palpitations and diarrhoea, and when to seek urgent care.

Guidelines For Proper Use — Counselling And Follow‑Up

How should pharmacists and prescribers counsel patients starting pletal?

Explain the dosing schedule clearly: 100 mg twice daily, taken 30 minutes before or two hours after meals.

Set expectations: clinical benefit may take up to twelve weeks and should be reassessed between four and twelve weeks, with discontinuation advised if there is no benefit at three months.

Discuss common side effects and red flags: severe palpitations, worsening breathlessness or signs of heart failure should prompt immediate medical review and stopping the medicine.

Review the medication list for CYP3A4 and CYP2C19 inhibitors and for other agents that increase bleeding risk.

Document counselling in dispensing software and My Health Record when possible, and use teach‑back to confirm understanding.

• Follow‑Up Timeline: Check adherence and walking distance at 4 weeks, reassess effectiveness at 8–12 weeks, and discontinue if no clear clinical improvement by 3 months.
• Rural Access: Arrange telehealth reviews and local pharmacy bridging if travel or mobility limits clinic follow‑up.
• Cultural Safety: Offer translated CMI and involve Indigenous health workers for Aboriginal and Torres Strait Islander patients.

Delivery Across Australia